Clinical Trials Logo

Ursodeoxycholic Acid clinical trials

View clinical trials related to Ursodeoxycholic Acid.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06091787 Not yet recruiting - Liver Regeneration Clinical Trials

Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy

Start date: October 15, 2023
Phase: N/A
Study type: Interventional

The goal of this open label randomized trial is to understand the role of oral ursodeoxycholic acid(UDCA) supplementation in the liver regeneration (in terms of liver function and anatomical growth) following right lobe donor hepatectomy. The main question it aims to answer are: - Does Ursodeoxycholic acid supplementation on patients undergoing donor hepatectomy improve anatomical liver regeneration after partial hepatectomy as compared to control group. - Does ursodeoxycholic acid improve liver regeneration in terms of liver function tests and biomarkers of liver regeneration(HGF, IL6, TNF Alpha, AFP, TGF Beta) as compared to control group.